Who owns TG THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TGTX from SEC Form 13F filings across 455 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 455 institutions disclosed 116.6M shares of TG THERAPEUTICS, INC. worth $6.50B — about 82.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
455
13F holders
$6.50B
value, 2026 filers
82.8%
of shares outstanding (116.6M sh)
81
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TGTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 22.6M | $1.26B | 0.0% | 16.1% | +2.7% |
| 2 | STATE STREET CORP | 8.5M | $473.5M | 0.0% | 6% | +9.0% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.9M | $439.6M | 0.0% | 5.6% | -1.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 6.3M | $349.0M | 0.0% | 4.4% | +1.7% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 3.7M | $206.6M | 0.0% | 2.6% | +1.7% |
| 6 | TWO SIGMA INVESTMENTS, LP | 3.4M | $188.0M | 0.1% | 2.4% | +36.5% |
| 7 | D. E. Shaw & Co., Inc. | 3.3M | $182.9M | 0.1% | 2.3% | -3.6% |
| 8 | CONGRESS ASSET MANAGEMENT CO | 2.6M | $145.4M | 0.9% | 1.9% | +0.2% |
| 9 | Soleus Capital Management, L.P. | 2.6M | $142.6M | 5.1% | 1.8% | -12.7% |
| 10 | GOLDMAN SACHS GROUP INC | 2.5M | $139.5M | 0.0% | 1.8% | +8.1% |
| 11 | BARCLAYS PLC | 2.4M | $135.2M | 0.0% | 1.7% | +153.0% |
| 12 | Clearbridge Investments, LLC | 2.1M | $119.4M | 0.1% | 1.5% | -19.2% |
| 13 | FRONTIER CAPITAL MANAGEMENT CO LLC | 2.0M | $113.3M | 1.2% | 1.4% | +450.6% |
| 14 | FIRST TRUST ADVISORS LP | 1.9M | $107.2M | 0.1% | 1.4% | +1053.0% |
| 15 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.9M | $106.6M | 0.0% | 1.4% | -31.0% |
| 16 | Hood River Capital Management LLC | 1.6M | $90.1M | 0.8% | 1.1% | +0.9% |
| 17 | Pictet Asset Management Holding SA | 1.6M | $89.4M | 0.1% | 1.1% | -10.3% |
| 18 | MORGAN STANLEY | 1.6M | $89.2M | 0.0% | 1.1% | -0.2% |
| 19 | NORTHERN TRUST CORP | 1.6M | $86.6M | 0.0% | 1.1% | +1.0% |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.5M | $86.1M | 0.0% | 1.1% | +17.6% |
| 21 | Nuveen, LLC | 1.5M | $81.7M | 0.0% | 1% | -9.9% |
| 22 | FMR LLC | 1.3M | $70.3M | 0.0% | 0.9% | +23.8% |
| 23 | BANK OF AMERICA CORP /DE/ | 1.1M | $64.0M | 0.0% | 0.8% | -12.4% |
| 24 | DIMENSIONAL FUND ADVISORS LP | 1.1M | $63.6M | 0.0% | 0.8% | -5.9% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 1.0M | $56.6M | 0.0% | 0.7% | +5.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.